Xvivo Perfusion AB (XVIVO) — Strategic Asset Allocation Index
Xvivo Perfusion AB (XVIVO) has a Strategic Asset Allocation Index of 10.1% as of December 2025. Strategic assets (PP&E of Skr213.88 Million plus long-term investments of Skr-) total Skr213.88 Million, measured against net assets of Skr2.11 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See XVIVO equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Xvivo Perfusion AB Strategic Asset Allocation Index (2011–2025)
This chart shows how Xvivo Perfusion AB's Strategic Asset Allocation Index has evolved across 14 annual periods from 2011 to 2025. As of December 2025, the index stands at 10.1%, representing strategic assets of Skr213.88 Million against net assets of Skr2.11 Billion SEK. For live market cap and overall valuation, see Xvivo Perfusion AB stock valuation.
Annual Strategic Asset Allocation Index for Xvivo Perfusion AB (2011–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Xvivo Perfusion AB from 2011 to 2025, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Xvivo Perfusion AB book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.1% | Skr213.88 Million | Skr213.88 Million | Skr- | Skr2.11 Billion | ▲ +3.2 pp |
| 2024 | 6.9% | Skr149.04 Million | Skr149.04 Million | Skr- | Skr2.16 Billion | ▲ +1.9 pp |
| 2023 | 5.0% | Skr97.55 Million | Skr97.55 Million | Skr- | Skr1.95 Billion | ▲ +1.7 pp |
| 2022 | 3.3% | Skr47.58 Million | Skr47.58 Million | Skr- | Skr1.43 Billion | ▲ +1.3 pp |
| 2021 | 2.0% | Skr26.30 Million | Skr26.30 Million | Skr- | Skr1.29 Billion | ▼ -0.1 pp |
| 2020 | 2.1% | Skr21.33 Million | Skr21.33 Million | Skr- | Skr1.01 Billion | ▼ -2.0 pp |
| 2019 | 4.1% | Skr23.78 Million | Skr23.55 Million | Skr223.00K | Skr577.52 Million | ▲ +1.2 pp |
| 2018 | 2.9% | Skr15.69 Million | Skr15.62 Million | Skr71.00K | Skr540.48 Million | ▼ -0.3 pp |
| 2017 | 3.2% | Skr16.35 Million | Skr16.28 Million | Skr71.00K | Skr504.33 Million | ▼ -1.6 pp |
| 2016 | 4.8% | Skr15.17 Million | Skr15.17 Million | Skr- | Skr316.41 Million | ▲ +0.9 pp |
| 2015 | 3.9% | Skr7.12 Million | Skr7.12 Million | Skr- | Skr184.87 Million | ▲ +3.2 pp |
| 2014 | 0.6% | Skr1.12 Million | Skr1.12 Million | Skr- | Skr176.18 Million | ▼ -0.3 pp |
| 2013 | 0.9% | Skr917.00K | Skr917.00K | Skr- | Skr96.64 Million | ▲ +0.2 pp |
| 2011 | 0.8% | Skr92.00K | Skr92.00K | Skr- | Skr11.91 Million | — |